REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMurray International Regulatory News (MYI)

Share Price Information for Murray International (MYI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 255.00
Bid: 254.00
Ask: 255.00
Change: 1.50 (0.59%)
Spread: 1.00 (0.394%)
Open: 254.00
High: 255.00
Low: 253.00
Prev. Close: 253.50
MYI Live PriceLast checked at -
Murray International is an Investment Trust

To achieve an above average dividend yield, with long term growth in dividends and capital ahead of inflation, by investing principally in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Murray International Trust (MYI)

8 Oct 2019 15:36

RNS Number : 1892P
Murray International Trust PLC
08 October 2019
 

 

London, UK, 8 October 2019

Edison issues review on Murray International Trust (MYI)

Murray International Trust (MYI) is a well-established investment trust, launched in 1907. Manager Bruce Stout runs a diversified portfolio of global equities and fixed income securities, aiming to achieve long-term capital growth while protecting capital during periods of market weakness, and generate an above-average level of income (the current dividend yield is 4.4%). The majority of the portfolio is invested in emerging markets: regions where the manager finds the most attractive opportunities, and which continue to employ orthodox economic policies, unlike many developed markets.

 

As shown in Exhibit 8, over the last three years, MYI has regularly traded at a premium; its current 0.6% discount to cum-income NAV compares with an average discount of 0.1% and average premiums of 0.8%, 0.8% and 3.1% over the last one, three, five and 10 years, respectively. The board has a progressive dividend policy, adding income to reserves when available and drawing down in other years when required. MYI currently offers a 4.4% dividend yield, which is the highest in the AIC Global Equity Income sector.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFMMGGDRVGLZM
Date   Source Headline
22nd Sep 202312:59 pmRNSNet Asset Value(s)
21st Sep 20235:18 pmRNSTransaction in Own Shares
21st Sep 202312:30 pmRNSNet Asset Value(s)
20th Sep 20235:19 pmRNSTransaction in Own Shares
20th Sep 202312:41 pmRNSNet Asset Value(s)
19th Sep 20235:10 pmRNSTransaction in Own Shares
19th Sep 202312:59 pmRNSNet Asset Value(s)
18th Sep 20235:40 pmRNSTransaction in Own Shares
18th Sep 20231:21 pmRNSGearing Disclosures
18th Sep 202312:27 pmRNSNet Asset Value(s)
15th Sep 20235:36 pmRNSTransaction in Own Shares
15th Sep 202312:21 pmRNSNet Asset Value(s)
14th Sep 20235:32 pmRNSPortfolio Disclosures
14th Sep 20235:31 pmRNSTransaction in Own Shares
14th Sep 202312:40 pmRNSNet Asset Value(s)
13th Sep 20235:27 pmRNSTransaction in Own Shares
13th Sep 20232:59 pmRNSDirector/PDMR Shareholding
13th Sep 202312:06 pmRNSNet Asset Value(s)
12th Sep 20235:31 pmRNSTransaction in Own Shares
12th Sep 202312:28 pmRNSNet Asset Value(s)
11th Sep 20235:38 pmRNSTransaction in Own Shares
11th Sep 20231:19 pmRNSGearing disclosure
11th Sep 202312:42 pmRNSNet Asset Value(s)
8th Sep 20235:18 pmRNSTransaction in Own Shares
8th Sep 202312:44 pmRNSNet Asset Value(s)
7th Sep 20235:17 pmRNSTransaction in Own Shares
7th Sep 202312:15 pmRNSNet Asset Value(s)
7th Sep 202310:01 amRNSMonth End Net Asset Value(s)
5th Sep 20235:22 pmRNSTransaction in Own Shares
5th Sep 202311:31 amRNSNet Asset Value(s)
4th Sep 20235:25 pmRNSTransaction in Own Shares
4th Sep 20231:38 pmRNSGearing Disclosures
4th Sep 202312:41 pmRNSNet Asset Value(s)
1st Sep 20239:58 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSDirectorate Change
31st Aug 20235:34 pmRNSTransaction in Own Shares
31st Aug 20231:14 pmRNSNet Asset Value(s)
31st Aug 202312:33 pmRNSDirector/PDMR Shareholding
30th Aug 20235:39 pmRNSTransaction in Own Shares
30th Aug 202312:19 pmRNSNet Asset Value(s)
29th Aug 20235:19 pmRNSTransaction in Own Shares
29th Aug 20233:48 pmRNSGearing disclosure
29th Aug 202312:31 pmRNSNet Asset Value(s)
25th Aug 20235:39 pmRNSTransaction in Own Shares
25th Aug 202312:12 pmRNSNet Asset Value(s)
25th Aug 202310:32 amRNSDoc re. Half Yearly Report
24th Aug 20235:31 pmRNSTransaction in Own Shares
24th Aug 202312:55 pmRNSNet Asset Value(s)
23rd Aug 20235:27 pmRNSTransaction in Own Shares
23rd Aug 202312:26 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.